Entitlement offer Completed
Recce Pharmaceuticals entitlement offer
A$15.8m raised
ASX: RCE
Advisers
Recce Pharmaceuticals
Issuer
Not disclosed
Lead managers
- Lead manager
- Co-manager
- Spark Plus (co)
- Issuer
- Recce Pharmaceuticals
- Structure
- Traditional non-renounceable entitlement offer
- Completed
- 3 Jun 2025
- Sector
- Biotech and pharmaceuticals
Similar deals
- Arovella Therapeutics placement Feb 2025 · A$15m · Biotech and pharmaceuticals
- Actinogen Medical placement Feb 2026 · A$17m · Biotech and pharmaceuticals
- Nyrada placement Sep 2026 · A$14m · Biotech and pharmaceuticals
- Paradigm Biopharmaceuticals placement Apr 2026 · A$14m · Biotech and pharmaceuticals
- Radiopharm Theranostics placement Jul 2026 · A$12.5m · Biotech and pharmaceuticals
Sources
- 3 Jun 2025 Successful Placement of Entitlement Offer Shortfall ASX